Nepafenac
SIGMA/SML0288 - ≥98% (HPLC)
Synonym: 2-
CAS Number: 78281-72-8
Empirical Formula (Hill Notation): C15H14N2O2
Molecular Weight: 254.28
MDL Number: MFCD08067732
Linear Formula: C15H14N2O2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | faintly yellow to dark yellow |
| form | powder |
| InChI | 1S/C15H14N2O2/c16-13(18)9 |
| InChI key | QEFAQIPZVLVERP-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | NC(=O)Cc1cccc(c1N)C(=O)c2 |
| solubility | DMSO: ≥5 mg/mL |
| storage temp. | room temp |
| Biochem/physiol Actions: | Nepafenac is a NSAID (nonsteroidal anti inflammatory drug) that is routinely used in opthamology to control pain following cataract surgery. |
| Biochem/physiol Actions: | Nepafenac is a NSAID (nonsteroidal anti inflammatory drug) used in opthamology. |
| Biochem/physiol Actions: | Nepafenac, a prodrug of amfenac, is used in the treatment of diabetic retinopathy. It is metabolized to its active form through intraocular enzymatic hydrolysis. Nepafenac has a molecular weight of 254.28 kDa and effectively penetrates through the cornea. Its molecule structure enables nepafenac to possess better permeability. Nepafenac has a low inhibitory effect on cyclooxygenase. |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS09 |
| Signal word | Warning |
| Hazard statements | H400 |
| Precautionary statements | P273 |
| Hazard Codes | N |
| Risk Statements | 50/53 |
| Safety Statements | 60-61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |


